• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经灌注的大鼠肾脏中末端连接修饰的寡核苷酸的肾脏处置特征

Renal disposition characteristics of oligonucleotides modified at terminal linkages in the perfused rat kidney.

作者信息

Sawai K, Miyao T, Takakura Y, Hashida M

机构信息

Department of Drug Delivery Research, Faculty of Pharmaceutical Sciences, Kyoto University, Japan.

出版信息

Antisense Res Dev. 1995 Winter;5(4):279-87. doi: 10.1089/ard.1995.5.279.

DOI:10.1089/ard.1995.5.279
PMID:8746777
Abstract

To clarify the renal disposition characteristics of oligonucleotides at the organ level, the renal handling of model end-capped oligonucleotides, 3'-methoxyethylamine 5'-biotin-decathymidylic acid containing phosphoramidate modifications at 3'- and 5'-terminal internucleoside linkages (T10) and its phosphorothioate (Ts10), were studied in the perfused rat kidney. In a single-pass indicator dilution experiment, venous outflow and urinary excretion patterns and tissue accumulation of radiolabeled oligonucleotides were evaluated under filtering or nonfiltering conditions. No significant binding to bovine serum albumin (BSA) in the perfusate was observed for T10, whereas more than 90% of Ts10 bound to BSA. The steady-state distribution volume of T10 calculated from the venous outflow pattern was larger than that of inulin, which corresponds to the extracellular volume of the kidney, whereas the distribution volume of Ts10 was larger than that of BSA (the intravascular volume). These results suggested their interaction with the vascular wall. Rapid urinary excretion was observed for T10, similar to inulin used as a marker of golmerular filtration rate. On the other hand, urinary excretion of Ts10 was greatly restricted due to its high binding ability (> 90%) to BSA in the perfusate. A significant amount of T10 and Ts10 was accumulated in the kidney (T10, 1.8% of injected dose; Ts10, 1.3%) compared with inulin (0.2%) and BSA (< 0.1%). The accumulation of these oligonucleotides was ascribed to both tubular reabsorption and uptake from the capillary side. In addition, the uptake of T10 from the capillary side was significantly inhibited by simultaneous injection of dextran sulfate, suggesting that the oligonucleotide was taken up as an anionic molecule. These findings will be useful information for the development of delivery systems for antisense oligonucleotides.

摘要

为了在器官水平上阐明寡核苷酸的肾脏处置特征,在灌注大鼠肾脏中研究了模型封端寡核苷酸、在3'-和5'-末端核苷间连接处以氨基磷酸酯修饰的3'-甲氧基乙胺5'-生物素-十聚胸苷酸(T10)及其硫代磷酸酯(Ts10)的肾脏处理情况。在单通道指示剂稀释实验中,在过滤或非过滤条件下评估了放射性标记寡核苷酸的静脉流出和尿排泄模式以及组织蓄积情况。未观察到T10与灌注液中的牛血清白蛋白(BSA)有明显结合,而超过90%的Ts10与BSA结合。根据静脉流出模式计算的T10稳态分布容积大于菊粉(对应于肾脏细胞外容积)的分布容积,而Ts10的分布容积大于BSA(血管内容积)的分布容积。这些结果表明它们与血管壁有相互作用。观察到T10的尿排泄迅速,类似于用作肾小球滤过率标志物的菊粉。另一方面,Ts10的尿排泄由于其与灌注液中BSA的高结合能力(>90%)而受到极大限制。与菊粉(0.2%)和BSA(<0.1%)相比,大量的T10和Ts10蓄积在肾脏中(T10,注射剂量的1.8%;Ts10,1.3%)。这些寡核苷酸的蓄积归因于肾小管重吸收和从毛细血管侧的摄取。此外,同时注射硫酸葡聚糖可显著抑制T10从毛细血管侧的摄取,表明该寡核苷酸作为阴离子分子被摄取。这些发现将为反义寡核苷酸递送系统的开发提供有用信息。

相似文献

1
Renal disposition characteristics of oligonucleotides modified at terminal linkages in the perfused rat kidney.经灌注的大鼠肾脏中末端连接修饰的寡核苷酸的肾脏处置特征
Antisense Res Dev. 1995 Winter;5(4):279-87. doi: 10.1089/ard.1995.5.279.
2
Disposition of oligonucleotides in isolated perfused rat kidney: involvement of scavenger receptors in their renal uptake.寡核苷酸在离体灌注大鼠肾脏中的处置:清道夫受体在其肾脏摄取中的作用。
J Pharmacol Exp Ther. 1996 Oct;279(1):284-90.
3
Disposition characteristics of model macromolecules in the perfused rat kidney.模型大分子在灌注大鼠肾脏中的处置特征
Biol Pharm Bull. 1993 Feb;16(2):158-62. doi: 10.1248/bpb.16.158.
4
Stability and pharmacokinetic characteristics of oligonucleotides modified at terminal linkages in mice.小鼠体内末端连接修饰的寡核苷酸的稳定性和药代动力学特征
Antisense Res Dev. 1995 Summer;5(2):115-21. doi: 10.1089/ard.1995.5.115.
5
Renal disposition of recombinant human interleukin-11 in the isolated perfused rat kidney.重组人白细胞介素-11在离体灌注大鼠肾脏中的肾处置情况。
Pharm Res. 1997 Jan;14(1):86-90. doi: 10.1023/a:1012063602856.
6
Disposition characteristics of protein drugs in the perfused rat kidney.蛋白质药物在灌注大鼠肾脏中的处置特征。
Pharm Res. 1993 Jun;10(6):823-7. doi: 10.1023/a:1018996808153.
7
Uptake characteristics of oligonucleotides in the isolated rat liver perfusion system.寡核苷酸在离体大鼠肝脏灌注系统中的摄取特性
Antisense Nucleic Acid Drug Dev. 1996 Fall;6(3):177-83. doi: 10.1089/oli.1.1996.6.177.
8
Isolated rat kidney perfused with dextran and bovine serum albumin: a stable model for investigating renal drug handling.用右旋糖酐和牛血清白蛋白灌注的离体大鼠肾脏:一种用于研究肾脏药物处理的稳定模型。
J Pharmacol Toxicol Methods. 2004 Mar-Apr;49(2):105-13. doi: 10.1016/j.vascn.2003.11.001.
9
Manipulation of renal disposition of human recombinant superoxide dismutase by chemical modification.通过化学修饰对人重组超氧化物歧化酶肾脏处置的调控
Biol Pharm Bull. 1994 Feb;17(2):296-301. doi: 10.1248/bpb.17.296.
10
Renal handling of high-density lipoproteins by isolated perfused kidneys.
Metabolism. 1984 May;33(5):432-8. doi: 10.1016/0026-0495(84)90143-4.

引用本文的文献

1
Understanding In Vivo Fate of Nucleic Acid and Gene Medicines for the Rational Design of Drugs.了解核酸和基因药物的体内命运以进行药物的合理设计。
Pharmaceutics. 2021 Jan 26;13(2):159. doi: 10.3390/pharmaceutics13020159.
2
Therapy with 2'-O-Me Phosphorothioate Antisense Oligonucleotides Causes Reversible Proteinuria by Inhibiting Renal Protein Reabsorption.2'-O-甲基硫代磷酸酯反义寡核苷酸治疗通过抑制肾脏蛋白质重吸收导致可逆性蛋白尿。
Mol Ther Nucleic Acids. 2019 Dec 6;18:298-307. doi: 10.1016/j.omtn.2019.08.025. Epub 2019 Sep 6.
3
Translational study of microRNAs and its application in kidney disease and hypertension research.
微小 RNA 的转化研究及其在肾脏病和高血压研究中的应用。
Clin Sci (Lond). 2012 May 1;122(10):439-47. doi: 10.1042/CS20110159.
4
Nanogels for oligonucleotide delivery to the brain.用于将寡核苷酸递送至大脑的纳米凝胶。
Bioconjug Chem. 2004 Jan-Feb;15(1):50-60. doi: 10.1021/bc034164r.
5
Antisense approaches to the gene therapy of cancer--'Recnac'.癌症基因治疗的反义方法——“Recnac”
Cancer Metastasis Rev. 1996 Sep;15(3):287-99. doi: 10.1007/BF00046343.